neurology

News in brief: New drug target could lead to non-opioid treatments for neuropathic pain; Plea for neurologists from voluntary assisted dying board; Global medical journals unite to call for climate crisis action

New drug target could lead to non-opioid treatments for neuropathic pain A new drug target could lead to safe and effective non-opioid neuropathic pain treatments, according to Australian researchers. Electrophysiology and preclinical pain models showed positive allosteric modulators (PAM) could bind the adenosine A1 receptor with higher selectivity and less side effects than previously investigated ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic